DOD appoints Torlarp Chaiyachuan as CEO, effective October 1st.

DOD officially appoints Torlarp Chaichaowan as Chief Executive Officer, effective October 1, 68. The appointment is intended to strengthen the organization's strategy and drive sustainable business expansion.

On October 1, 2568, DOD Biotech Public Company Limited (DOD) informed the Stock Exchange of Thailand that its Board of Directors had approved the official appointment of Mr. Torlap Chaichao as Chief Executive Officer, effective from today (October 1, 2568).

Mr. Torlap Chaichai, Chief Executive Officer of DOD, revealed that upon officially assuming the position, he will accelerate the organization's progress towards success according to the plans set previously during his tenure as acting Chief Executive Officer. He will focus on adjusting business strategies to align with the current economic climate.

By leveraging its strengths in innovation, continuous product research and development, and the production of high-quality products comparable to pharmaceutical manufacturing standards, which are guaranteed by GMP, GHPs, HACCP, ISO 22000, ISO 14001, and ISO/IEC 17025, the company has been elevated to a global "Manufacturing Brand Company" in health and beauty supplements.

Meanwhile, DOD has applied AI (artificial intelligence) innovation to its business to enhance its capabilities and meet the needs of all customer segments across all dimensions. This is particularly true when it comes to in-depth consumer behavioral data analysis, enabling a clear assessment of future product consumption trends and further development into future product research and development.

Furthermore, DOD has clearly announced its focus on expanding into online markets, particularly promoting the company as a "Manufacturing Brand Company" through social media channels to expand its customer base to new audiences. The company is also open to new business partners to join the team and create business opportunities for sustainable growth.

DOD prioritizes maintaining high standards and quality, coupled with a commitment to product development. This is achieved through our R&D team, which invents formulas or co-develops formulas with customers for further product development. Our innovative production lines in our modern factory are efficient and comprehensive in every aspect of the manufacturing process. This recognition has led to repeat orders, which average 50-60% of total monthly sales.

Read all interesting business news here.